Sanstar Limited ("Sanstar" or the "Company") (BSE: 544217 | NSE: SANSTAR), one of the largest producers of maize-based specialty products and ingredient solutions in India, today announced the commissioning of its expanded native starch manufacturing capacity at its Dhule facility in Maharashtra.
This expansion marks a key milestone in the Company's growth journey and is part of its broader capacity expansion plan funded through IPO proceeds. The entire amount of Rs. 1,816 million allocated towards the Dhule expansion has now been fully utilized.
With this commissioning, Sanstar has taken a significant step towards increasing its total installed capacity from 1,100 TPD to 2,350 TPD, positioning itself to become one of the largest manufacturers in India's maize-based specialty products industry.
The Shirpur plant, following this capacity expansion, will become one of the largest plants in India in terms of operating capacity at a single location.
The expansion is being implemented in two phases. While the native starch capacity has now been commissioned, the derivatives facility is expected to be commissioned within FY2026-27.
The Dhule facility, strategically located near key maize-growing regions and major ports, provides strong logistical advantages and supports efficient sourcing and export operations. The expanded capacity is expected to improve operational efficiencies, enhance scale benefits and strengthen the Company's ability to cater to growing domestic and international demand.
Commenting on the development, Mr. Gouthamchand Chowdhary, Chairman and Managing Director said: "The commissioning of our expanded native starch capacity at Dhule marks an important milestone in Sanstar's growth journey. This expansion strengthens our manufacturing capabilities and enhances our ability to serve a diverse and growing customer base across industries.
Despite originally planning for a 1,000 MTPD expansion at the time of the IPO, the company has successfully scaled its installed crushing capacity to 1,250 MTPD, demonstrating strong execution capability and operational efficiency.
With the full utilization of IPO proceeds towards this project, we are now well positioned to scale our operations. The upcoming commissioning of the derivatives facility will further enhance our product portfolio, enabling us to move towards higher value-added offerings.
As demand for maize-based specialty ingredients continues to grow across food, pharmaceuticals and industrial applications, we remain focused on leveraging our expanded capacity, strengthening customer relationships and driving sustainable long-term growth."